$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
丙型肝炎患者中肝细胞癌发病率和生存期趋势研究
2025-10-19 11:44:20
Check Details
丙肝治疗选择药物吉二代
2025-10-19 11:44:20
Check Details
直接抗病毒药物使丙肝患者获益
2025-10-19 11:44:20
Check Details
索非布韦和达卡他韦治疗丙肝效果优异
2025-10-19 11:44:20
Check Details
及早治疗,九成的丙肝患者能被治愈
2025-10-19 11:44:20
Check Details
直接抗病毒药物改善丙肝患者的糖尿病症状
2025-10-19 11:44:20
Check Details
丙肝患者需要及时接受治疗
2025-10-19 11:44:20
Check Details
研究表明,丙肝患者患肾脏疾病的风险较高
2025-10-19 11:44:20
Check Details
索非达卡治疗丙肝减轻抑郁症状
2025-10-19 11:44:20
Check Details
丙肝最有效的治疗方法
2025-10-19 11:44:20
Check Details
丙肝传播方式及高危人群
2025-10-19 11:44:20
Check Details
丙肝药物艾尔巴韦格拉瑞韦片复方制剂临床试验
2025-10-19 11:44:20
Check Details
1
2
...
5840
5841
5842
5843
5844
5845
5846
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
2
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
3
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
4
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
5
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
6
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
7
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
8
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
9
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
10
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
11
Daraxonrasib Pregnancy, Lactation and Contraception Safety
12
Afatinib Side Effects and Safety Management